DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,399,607 | +153.8% | 37,621 | +153.7% | 0.16% | +78.7% |
Q1 2024 | $3,703,348 | -83.8% | 14,830 | -85.0% | 0.09% | -68.6% |
Q4 2023 | $22,887,854 | +267.9% | 98,936 | +294.5% | 0.28% | +45.1% |
Q3 2023 | $6,221,356 | +342.4% | 25,076 | +328.0% | 0.20% | +314.9% |
Q2 2023 | $1,406,160 | +26183.4% | 5,859 | -72.4% | 0.05% | -72.4% |
Q1 2023 | $5,350 | +82.3% | 21,226 | +92.0% | 0.17% | +39.3% |
Q4 2022 | $2,935 | -100.0% | 11,057 | -81.0% | 0.12% | -50.0% |
Q3 2022 | $15,006,000 | +142.2% | 58,095 | +137.7% | 0.24% | +75.5% |
Q2 2022 | $6,195,000 | -75.9% | 24,436 | -72.1% | 0.14% | -43.5% |
Q1 2022 | $25,733,000 | +111.2% | 87,728 | +136.9% | 0.25% | +16.6% |
Q4 2021 | $12,182,000 | +179.9% | 37,026 | +159.0% | 0.21% | +90.1% |
Q3 2021 | $4,352,000 | +57.9% | 14,296 | +39.2% | 0.11% | +54.2% |
Q2 2021 | $2,756,000 | -76.8% | 10,269 | -80.6% | 0.07% | -64.0% |
Q1 2021 | $11,898,000 | +187.3% | 52,861 | +183.5% | 0.20% | +57.5% |
Q4 2020 | $4,142,000 | +68.7% | 18,645 | +63.6% | 0.13% | +370.4% |
Q3 2020 | $2,455,000 | +77.6% | 11,400 | +45.9% | 0.03% | -52.6% |
Q2 2020 | $1,382,000 | +13.3% | 7,815 | -11.4% | 0.06% | -23.0% |
Q1 2020 | $1,220,000 | -12.8% | 8,817 | -9.0% | 0.07% | -22.9% |
Q3 2019 | $1,399,000 | +34875.0% | 9,686 | +34492.9% | 0.10% | – |
Q2 2019 | $4,000 | -99.6% | 28 | -99.7% | 0.00% | -100.0% |
Q1 2019 | $1,135,000 | -36.6% | 8,595 | -50.5% | 0.07% | -46.5% |
Q4 2018 | $1,791,000 | +2196.2% | 17,372 | +2306.1% | 0.13% | +2050.0% |
Q3 2018 | $78,000 | -94.2% | 722 | -94.7% | 0.01% | -92.1% |
Q2 2018 | $1,355,000 | +160.1% | 13,731 | +144.6% | 0.08% | +13.4% |
Q4 2017 | $521,000 | +543.2% | 5,613 | +493.3% | 0.07% | +857.1% |
Q3 2017 | $81,000 | +912.5% | 946 | +846.0% | 0.01% | +600.0% |
Q2 2017 | $8,000 | -95.4% | 100 | -95.0% | 0.00% | -94.1% |
Q1 2017 | $173,000 | -88.6% | 2,020 | -89.6% | 0.02% | -89.7% |
Q4 2016 | $1,516,000 | +1132.5% | 19,476 | +1136.6% | 0.16% | +1275.0% |
Q3 2016 | $123,000 | -47.4% | 1,575 | -32.3% | 0.01% | -45.5% |
Q2 2016 | $234,000 | +23300.0% | 2,325 | +25733.3% | 0.02% | – |
Q1 2016 | $1,000 | -88.9% | 9 | -91.0% | 0.00% | -100.0% |
Q3 2015 | $9,000 | -91.9% | 100 | -92.3% | 0.00% | -90.0% |
Q2 2015 | $111,000 | +753.8% | 1,300 | +766.7% | 0.01% | +400.0% |
Q1 2015 | $13,000 | -83.3% | 150 | -85.6% | 0.00% | -80.0% |
Q1 2014 | $78,000 | +1850.0% | 1,045 | +2077.1% | 0.01% | +900.0% |
Q4 2013 | $4,000 | -99.7% | 48 | -99.7% | 0.00% | -99.3% |
Q3 2013 | $1,281,000 | +726.5% | 18,480 | +656.8% | 0.14% | +961.5% |
Q2 2013 | $155,000 | – | 2,442 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |